-
DE
K51.8 – Other Ulcerative Colitis | ICD-10
K51.8 is the ICD-10 code for other forms of ulcerative colitis, a chronic inflammatory bowel disease affecting the lining of the large intestine.
Add as Preferred SourceThings worth knowing about "K51.8"
K51.8 is the ICD-10 code for other forms of ulcerative colitis, a chronic inflammatory bowel disease affecting the lining of the large intestine.
What Does the ICD-10 Code K51.8 Mean?
The ICD-10 code K51.8 refers to other forms of ulcerative colitis that do not fit the more specific subcategories K51.0 through K51.5. Ulcerative colitis is a chronic inflammatory bowel disease (IBD) characterized by recurring inflammation of the mucous membrane lining the large intestine (colon) and rectum. Code K51.8 covers disease presentations and anatomical distributions that do not correspond to any of the other clearly defined subtypes.
Causes
The exact cause of ulcerative colitis is not yet fully understood. It is thought to result from a combination of several factors:
- Genetic predisposition: Certain gene variants increase the risk of developing the disease.
- Dysregulated immune response: The immune system mistakenly attacks the body's own intestinal lining.
- Changes in gut flora (microbiome): An imbalance of intestinal bacteria may contribute to inflammation.
- Environmental factors: Diet, stress, and previous infections may act as triggers or aggravating factors.
Symptoms
Symptoms of ulcerative colitis can vary depending on the severity and location of inflammation. Common complaints include:
- Bloody or mucus-containing diarrhea
- Cramping abdominal pain, often in the lower left abdomen
- Urgent and sudden need to defecate (tenesmus)
- General fatigue and exhaustion
- Weight loss in severe cases
- Fever during acute flares
- Anemia due to intestinal bleeding
The disease typically follows a relapsing-remitting course: periods of active inflammation (flares) alternate with symptom-free periods (remissions).
Diagnosis
Diagnosis of ulcerative colitis involves a combination of examinations:
- Colonoscopy with biopsy: The most important diagnostic procedure, allowing direct visualization and tissue sampling.
- Laboratory tests: Blood count, inflammatory markers (e.g., CRP, fecal calprotectin).
- Imaging: Abdominal ultrasound or MRI to assess the intestinal wall.
- Stool tests: To exclude infectious causes of diarrhea.
Treatment
Treatment of ulcerative colitis aims to control flares and achieve sustained remission. Therapy is tailored to disease severity and extent:
Medication
- Aminosalicylates (e.g., mesalazine): First-line therapy for mild to moderate disease; reduce inflammation in the intestinal lining.
- Corticosteroids (e.g., prednisolone): Used for short-term management of acute flares.
- Immunosuppressants (e.g., azathioprine): For long-term maintenance of remission.
- Biologics (e.g., TNF-alpha inhibitors such as infliximab): For moderate to severe disease or cases not responding to other treatments.
- JAK inhibitors and other targeted therapies: Newer options for treatment-refractory cases.
Surgery
In severe cases that do not respond to medication, or when complications arise (e.g., major bleeding, toxic megacolon), surgery may be necessary. In some patients, the entire colon is removed (colectomy).
Diet and Lifestyle
A balanced diet can help improve tolerance of food. During a flare, a low-fiber, easily digestible diet is often recommended. Stress management and regular medical check-ups are also important components of long-term care.
Prognosis
Ulcerative colitis is a chronic condition that may persist throughout a patient's lifetime. However, with modern therapies, stable remission can be achieved in many patients and quality of life can be significantly improved. Long-term patients face an increased risk of colorectal cancer, making regular surveillance colonoscopies an important part of ongoing care.
References
- World Health Organization (WHO): ICD-10 International Classification of Diseases, 10th Revision, Chapter XI, K51 – Ulcerative colitis.
- Harbord M. et al. – Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Journal of Crohn's and Colitis, 2017.
- Rubin D.T. et al. – ACG Clinical Guideline: Ulcerative Colitis in Adults. American Journal of Gastroenterology, 2019.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Skip product gallery
Subscription available
Floral
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®30 lozenges
Regular price:
22,90 €
Discount
Subscription available
Lactoferrin 60 Capsules
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
60 Capsules
Sale price:
50,00 €
Regular price:
59,90 €
Subscription available
Multivitamin Mineral Complex
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
30 Capsules
Regular price:
29,90 €
Subscription available
Natural Iron
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
30 Capsules
Regular price:
35,90 €